BeStock  
Stocks › Biotechnology › RGNX

Regenxbio RGNX

US equityMarket cap rank #3612Biotechnology
$7.16 −$0.02 (-0.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.12 -0.56%
Open$7.00
Prev close$7.18
Day range$6.86 – $7.30
Volume1.06M
Market cap$473.44M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$20.91+192.0% vs. price
  • Buy 82%
  • Hold 18%
Low $10.00Now $7.16Avg $20.91High $42.00

Recent rating changes

The last 20 actions on file set price targets from $10.00 to $42.00, averaging $20.60.

DateFirmRatingTarget
6 Nov 2026 Mizuho Securities BUY $18.00
6 Nov 2026 BofA Securities BUY $14.00
6 Nov 2026 Baird BUY $25.00
6 Nov 2026 Morgan Stanley BUY $18.00
6 Nov 2026 H.C. Wainwright BUY $21.00
6 Nov 2026 Barclays HOLD $12.00
5 Nov 2026 RBC Capital BUY $19.00
29 Oct 2026 Mizuho Securities BUY $19.00
21 Oct 2026 BofA Securities BUY $15.00
21 Oct 2026 Stifel BUY $42.00
20 Oct 2026 Morgan Stanley BUY $18.00
20 Oct 2026 Goldman Sachs HOLD $10.00
13 Oct 2026 Barclays HOLD $12.00
12 Oct 2026 Leerink Partners BUY $19.00
5 Oct 2026 Mizuho Securities BUY $22.00
25 Sep 2026 Stifel BUY $42.00
25 Sep 2026 H.C. Wainwright BUY $21.00
21 Sep 2026 BofA Securities BUY $15.00
26 Aug 2026 H.C. Wainwright BUY $21.00
25 Aug 2026 Baird BUY $29.00

Discussion

No comments yet — be the first to weigh in on RGNX.

Sign in to join the discussion.

Scroll to Top